Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network
Crossref DOI link: https://doi.org/10.1007/s00280-016-3112-9
Published Online: 2016-07-20
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shantakumar, Sumitra
Nordstrom, Beth L.
Djousse, Luc
Hall, Susan A.
Gagnon, David R.
Fraeman, Kathy H.
van Herk-Sukel, Myrthe
Chagin, Karen
Nelson, Jeanenne
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-07-20